Anticancer Potential of Quercetin on Oral Squamous Cell Carcinoma: A Scoping Review and Molecular Docking

Overview

Journal Eur J Dent

Publisher Thieme

Specialty Dentistry

Date 2024 Sep 30

PMID 39348855

Authors

Dhona Afriza

Utmi Arma

Raefany Faslah

Wastuti Hidayati Suriyah

Affiliations

Soon will be listed here.

Abstract

Oral squamous cell carcinoma (OSCC) is a type of cancer that has a low survival rate and high recurrence and metastasis rates. To date, there is still no effective treatment for OSCC. Various types of cancer, including OSCC, have reported quercetin to act as an anticancer agent, but there is no clear research data on how it may affect OSCC. To determine the anticancer potential of quercetin in OSCC, we conducted a scoping review, and to determine the interaction of quercetin with one of the proteins that plays a role in carcinogenesis, namely, BCL-2, we conducted molecular docking. The scoping review process was conducted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews. The scoping review was searched by collecting articles related to the research topic in Google Scholar, PubMed, ScienceDirect, Cochrane, and EBSCOhost databases. All of the literature records found during the search were imported into the Mendeley software to remove duplication. Nine studies were generated after the titles and abstracts were reviewed according to the inclusion and exclusion criteria. After the full-text screening, no studies were excluded, leaving nine publications determined to be eligible for inclusion in the scoping review. Quercetin showed effects on inhibiting cancer invasion, migration, proliferation, and many protein expressions, as well as increasing cell apoptosis. Molecular docking was done for quercetin and BCl-2 protein. Doxorubicin was utilized as a comparison ligand. The study was utilized using AutoDock Vina, AutoDock Tools 1.5.6, Biovia Discovery Studio 2021, and PyMol. Molecular docking indicated quercetin has a strong binding affinity with BCl-2 protein (ΔG -7.2 kcal/mol). Both scoping review and molecular docking revealed that quercetin is a promising candidate for anticancer agent.

References

Young T, Abel R, Kim B, Berne B, Friesner R . Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding. Proc Natl Acad Sci U S A. 2007; 104(3):808-13. PMC: 1783395. DOI: 10.1073/pnas.0610202104. View

Zlotogorski A, Dayan A, Dayan D, Chaushu G, Salo T, Vered M . Nutraceuticals as new treatment approaches for oral cancer--I: Curcumin. Oral Oncol. 2012; 49(3):187-91. DOI: 10.1016/j.oraloncology.2012.09.015. View

Finn N, Findley H, Kemp M . A switching mechanism in doxorubicin bioactivation can be exploited to control doxorubicin toxicity. PLoS Comput Biol. 2011; 7(9):e1002151. PMC: 3174179. DOI: 10.1371/journal.pcbi.1002151. View

Lipinski C, Lombardo F, Dominy B, Feeney P . Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001; 46(1-3):3-26. DOI: 10.1016/s0169-409x(00)00129-0. View

Huang C, Liu S, Ho T, Lee K, Fang K, Lo W . Quercetin induces tongue squamous cell carcinoma cell apoptosis via the JNK activation-regulated ERK/GSK-3α/β-mediated mitochondria-dependent apoptotic signaling pathway. Oncol Lett. 2022; 23(3):78. PMC: 8771640. DOI: 10.3892/ol.2022.13198. View

Sachdeva A, Dhawan D, Jain G, Yerer M, Collignon T, Tewari D . Novel Strategies for the Bioavailability Augmentation and Efficacy Improvement of Natural Products in Oral Cancer. Cancers (Basel). 2023; 15(1). PMC: 9818473. DOI: 10.3390/cancers15010268. View

Wei L, Surma M, Gough G, Shi S, Lambert-Cheatham N, Chang J . Dissecting the Mechanisms of Doxorubicin and Oxidative Stress-Induced Cytotoxicity: The Involvement of Actin Cytoskeleton and ROCK1. PLoS One. 2015; 10(7):e0131763. PMC: 4489912. DOI: 10.1371/journal.pone.0131763. View

Tricco A, Lillie E, Zarin W, OBrien K, Colquhoun H, Levac D . PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018; 169(7):467-473. DOI: 10.7326/M18-0850. View

Kim S, Lee E, Kim D, Kim H, Park H . Quercetin Inhibits Cell Survival and Metastatic Ability via the EMT-mediated Pathway in Oral Squamous Cell Carcinoma. Molecules. 2020; 25(3). PMC: 7037689. DOI: 10.3390/molecules25030757. View

10.

Terefe E, Ghosh A . Molecular Docking, Validation, Dynamics Simulations, and Pharmacokinetic Prediction of Phytochemicals Isolated From Against the HIV-1 Reverse Transcriptase. Bioinform Biol Insights. 2022; 16:11779322221125605. PMC: 9516429. DOI: 10.1177/11779322221125605. View

11.

Chan C, Lien C, Lee M, Huang C . Quercetin suppresses cellular migration and invasion in human head and neck squamous cell carcinoma (HNSCC). Biomedicine (Taipei). 2016; 6(3):15. PMC: 4980310. DOI: 10.7603/s40681-016-0015-3. View

12.

Juneja S, Chaitanya N, Agarwal M . Immunohistochemical expression of Bcl-2 in oral epithelial dysplasia and oral squamous cell carcinoma. Indian J Cancer. 2016; 52(4):505-10. DOI: 10.4103/0019-509X.178411. View

13.

Singh V, Singh R, Kujur P, Singh R . Combination of Resveratrol and Quercetin Causes Cell Growth Inhibition, DNA Damage, Cell Cycle Arrest, and Apoptosis in Oral Cancer Cells. Assay Drug Dev Technol. 2020; 18(5):226-238. DOI: 10.1089/adt.2020.972. View

14.

Kaur G, Dufour J . Cell lines: Valuable tools or useless artifacts. Spermatogenesis. 2012; 2(1):1-5. PMC: 3341241. DOI: 10.4161/spmg.19885. View

15.

Salehi B, Lopez-Jornet P, Pons-Fuster Lopez E, Calina D, Sharifi-Rad M, Ramirez-Alarcon K . Plant-Derived Bioactives in Oral Mucosal Lesions: A Key Emphasis to Curcumin, Lycopene, Chamomile, , Green Tea and Coffee Properties. Biomolecules. 2019; 9(3). PMC: 6468600. DOI: 10.3390/biom9030106. View

16.

Butnariu M, Quispe C, Sharifi-Rad J, Pons-Fuster E, Lopez-Jornet P, Zam W . Naturally-Occurring Bioactives in Oral Cancer: Preclinical and Clinical Studies, Bottlenecks and Future Directions. Front Biosci (Schol Ed). 2022; 14(3):24. DOI: 10.31083/j.fbs1403024. View

17.

Du L, Ma S, Wen X, Chai J, Zhou D . Oral squamous cell carcinoma cells are resistant to doxorubicin through upregulation of miR‑221. Mol Med Rep. 2017; 16(3):2659-2667. PMC: 5547975. DOI: 10.3892/mmr.2017.6915. View

18.

Angellotti G, Di Prima G, Belfiore E, Campisi G, De Caro V . Chemopreventive and Anticancer Role of Resveratrol against Oral Squamous Cell Carcinoma. Pharmaceutics. 2023; 15(1). PMC: 9866019. DOI: 10.3390/pharmaceutics15010275. View

19.

Chen L, Xia J, Wu J, Chen Y, Qiu C . Quercetin suppresses cell survival and invasion in oral squamous cell carcinoma via the miR-1254/CD36 cascade . Hum Exp Toxicol. 2021; 40(9):1413-1421. DOI: 10.1177/0960327121991912. View

20.

Zhang W, Yin G, Dai J, Sun Y, Hoffman R, Yang Z . Chemoprevention by Quercetin of Oral Squamous Cell Carcinoma by Suppression of the NF-κB Signaling Pathway in DMBA-treated Hamsters. Anticancer Res. 2017; 37(8):4041-4049. DOI: 10.21873/anticanres.11789. View